Dr Reddys Laboratories Ltd Share Price
(DRREDDY)
₹1163.6▲0.45%
as on 04:01PM, 17 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -0.73 % |
3 Month Return | -10.65 % |
1 Year Return | -2.1 % |
Market Stats | |
Previous Close | ₹1,158.40 |
Open | ₹1,150.10 |
Volume | 27.88L |
Upper Circuit | ₹1,274.20 |
Lower Circuit | ₹1,042.60 |
Market Cap | ₹97,097.23Cr |
P/E Ratio
18.04
PEG Ratio
11.07
Market Cap
₹97,097.23 Cr
P/B Ratio
4.22
EPS
66.882
Dividend Yield
0.65
Sector
Pharmaceuticals
ROE
19.42
based on 38 analysts
36.84%
Buy
26.32%
Hold
36.84%
Sell
Based on 38 analysts offering long term price targets for Dr Reddy's Laboratories. An average target of ₹1326.5
Source: S&P Global Market Intelligence
Dr Reddy's Laboratories price forecast by 38 analysts
Upside of14.00%
High
₹1723
Target
₹1326.50
Low
₹943
Dr Reddy's Laboratories target price ₹1326.5, a slight upside of 14% compared to current price of ₹1163.6. According to 38 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Dr Reddy's Laboratories revenue growth forecast
Expected growth rate Q1, FY2027:25.02%
Forecast
Actual
Including amortisation and stock based compensations
Dr Reddy's Laboratories EPS growth forecast
EPS estimate Q1, FY2027:
Forecast
Actual
Source: S&P Global Market Intelligence
Dr. Reddy's Laboratories Faces Challenges Amidst Growth Plans - 16 Apr, 2025
Dr Reddy’s Shares Rise Amid Denials and Acquisitions - 15 Apr, 2025
Dr Reddy's Denies Workforce Cost Reduction Claims - 14 Apr, 2025
Dr Reddy's Laboratories Implements Major Downsizing - 13 Apr, 2025
Dr Reddy's Faces Tax Demand of Rs 2,396 Crore - 11 Apr, 2025
Dr Reddy's Reports Profit Amid Stock Decline - 10 Apr, 2025
Dr Reddy's Faces Tariff Concerns Amid IT Partnership - 09 Apr, 2025
Dr. Reddy's Faces Tax Notice Amid Earnings Report - 05 Apr, 2025
Dr Reddy's Laboratories Faces Mixed Performance - 04 Apr, 2025
Dr Reddys Shares Surge on US Tariff Relief - 03 Apr, 2025
Dr Reddy's Faces Margin Pressure from Tariffs - 02 Apr, 2025
Concerns Over Tariffs Impacting Pharma Sector - 30 Mar, 2025
Dr Reddys Partners with Bio-Thera for Biosimilars - 26 Mar, 2025
Dr Reddys Schedules Meeting, Completes Facility Sale - 24 Mar, 2025
Dr Reddys Sells Louisiana Subsidiary - 23 Mar, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 4 quarters, 7.31K Cr → 8.53K Cr (in ₹), with an average increase of 5.0% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, 1.25K Cr → 1.41K Cr (in ₹), with an average increase of 11.2% per quarter
MF Holding Up
Mutual Funds have increased holdings from 10.86% to 11.14% in Dec 2024 quarter
Retail Holding Up
Retail Investor have increased holdings from 9.97% to 10.22% in Dec 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 26.64% of holdings in Dec 2024 quarter
Price Dip
In the last 1 month, DRREDDY stock has moved down by -0.7%
FII Holding Down
Foreign Institutions have decreased holdings from 27.53% to 26.85% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 26.64% | 0.00 | |
Foreign Institutions | 26.85% | ||
Mutual Funds | 11.14% | 2.57 | |
Retail Investors | 10.22% | 2.49 | |
Others | 25.15% | 0.64 |
Dr Reddy's Laboratories in the last 5 years
Lowest (3.37x)
October 27, 2019
Today (18.04x)
April 17, 2025
Industry (53.02x)
April 17, 2025
Highest (53.88x)
December 18, 2020
Dr Reddys Laboratories Ltd’s net profit jumped 2.38% since last year same period to ₹1,413.70Cr in the Q3 2024-2025. On a quarterly growth basis, Dr Reddys Laboratories Ltd has generated 12.58% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Dr Reddys Laboratories Ltd has declared dividend of ₹40 - translating a dividend yield of 6.88%.
Read More about DividendsBearish
Neutral
Bullish
Dr Reddys Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
HOLD | ₹97,097.23 Cr | 10.26% | 0.52 | ₹5,577 Cr | ₹28,011 Cr | |
HOLD | ₹1,49,724.28 Cr | 28.15% | 0.50 | ₹1,600 Cr | ₹7,845 Cr | |
BUY | ₹1,10,152.27 Cr | 35.85% | 0.67 | ₹1,656 Cr | ₹10,727 Cr | |
BUY | ₹39,775.88 Cr | -1.49% | 0.58 | ₹1,297 Cr | ₹14,755 Cr | |
HOLD | ₹23,879.80 Cr | -4.07% | 0.50 | ₹772 Cr | ₹5,664 Cr |
Organisation | Dr Reddy's Laboratories |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Dr Reddys Laboratories Ltd share price today stands at ₹1163.6, Open: ₹1150.1, Previous Close: ₹1158.4, High: ₹1173.6, Low: ₹1150.1, 52 Week High: ₹1421.49, 52 Week Low: ₹1020.
Today's traded volume of Dr Reddys Laboratories Ltd(DRREDDY) is 27.88L.
Today's market capitalisation of Dr Reddys Laboratories Ltd(DRREDDY) is ₹97097.23Cr.
Dr Reddys Laboratories Ltd (DRREDDY) share price is ₹1163.6. It is down -18.14% from its 52 Week High price of ₹1421.49
Dr Reddys Laboratories Ltd (DRREDDY) share price is ₹1163.6. It is up 14.08% from its 52 Week Low price of ₹1020